Diaverum presents new corporate logo at ASN Kidney Week
Munich/San Diego – 5 November 2015: Diaverum, one of the leading renal care providers worldwide, is presenting its service portfolio and medical studies at the ASN Kidney Week in San Diego, California. At the exhibition, the company launches its new logo to an external audience.
Evolving the Diaverum logo
“We are putting the patient in the centre of everything we do and the new logo is now reflecting this focus,” explains Christina Sterner at the start of the exhibition of ASN Kidney week. “The icon, that we added to the Diaverum word mark, describes our dynamic and caring approach. It symbolises the process of revitalisation, that our patients are undergoing during their treatment, and our commitment to provide the best care”.
The new unique icon consists of a “p” for patient and a “d” for Diaverum joined together in a modern and lively manner. Coloured in the typical Diaverum orange and combined with the Diaverum word mark, it stands for the dedication to patient focus as well as constant development.
Diaverum started as Gambro Healthcare more than 20 years ago and has been operating under the name “Diaverum” since 2008. Globally Diaverum is known for its excellent medical staff and the warm and friendly atmosphere that is it creating in its clinics, with the aim of providing a revitalising experience to renal patients. “The Diaverum orange is already transporting our key values competent, inspiring and passionate. With the new logo we are taking the next step in communicating our brand to renal patients, their relatives, the medical community and our business partner in 20 countries worldwide,” Christina Sterner adds.
The new logo will be rolled out to all Diaverum clinics and offices over the next months.
Diaverum posters at ASN
On Friday, 6 November, 10-12am, and Saturday, 7 November, 10-12am, the Diaverum physicians Dr. Staffan Schön and Dr. Marietta Török, will present the following posters at ASN:
- FR‑PO648: Glucose Targets for Preventing Diabetic Kidney Disease and Its Progression: A Meta-Analysis
- SA‑PO739: Neurocognitive Functioning and Association with Clinical Outcomes in Adults with End-Stage Kidney Disease: The COGNITIVE-HD Study
- SA‑PO821: Continuous Erythropoiesis Receptor Activator (CERA) for the Anemia of Chronic Kidney Disease (CKD): A Meta-Analysis of Randomized Controlled Trials
The Diaverum booth is located in the main exhibition hall, booth No 430.
Press Contact
Ulrike Beringer
Corporate Communications Diaverum
E-mail: Ulrike.Beringer@diaverum.com
Phone: +49 89 45 2444 124
About Diaverum
Diaverum is a global renal care provider with a clear patient focus. As one of the world’s leading renal care providers we stand for excellent medical quality, renal care services and a patient-centred research. Being product-independent also gives us the flexibility to offer individual treatments for the individual needs of our patients and by coordinating our patients’ healthcare needs, we are improving their quality of life. At the same time we are creating value in the healthcare system by optimising the use of healthcare budgets — for the benefit of the patient and the society. Our experience in renal care dates back more than 20 years, when the first dialysis clinic was established, under the former name Gambro Healthcare, defining our Swedish roots. Today 9,000 employees care for 27,000 patients in 20 countries in Europe, Latin America, Middle East/Asia and Australia. The corporate office is located in Munich, Germany. www.diaverum.com
Tags: